Friday, February 29, 2008


Kathleen Doheny, The New York Times, Tues, Sept.13, 2005
"High doses of vitamin C administered intravenously can fight cancer -- at least in the laboratory, researchers report.

"(The study) examined the body's absorption of the nutrient and found that while oral intake does reach a saturation point, when you give doses intravenously they go through the roof in the blood and then they are cleared, said lead researcher Dr. Mark Levine (chief of the molecular and clinical nutrition section and senior staff physician, National Institute of Diabetes & Digestive & Kidney Diseases). According to Levine, a 10 gram dose (10,000 milligrams) of vitamin C given intravenously produces bloodstream concentrations more than 25-fold higher than concentrations achieved from the same oral dose.

"Some antibiotics are poorly absorbed when given orally but fight infections effectively when given intravenously, and Levine and his team thought that might be the case with vitamin C and cancer. Working with cell lines in the laboratory, they used high doses of vitamin C that could only be achieved by IV administration.

At the highest concentration of ascorbic acid, if given intravenously, they don't touch normal cells and they kill lots of cancer cells. We don't know why, Levine said."

(Editor’s note: Yes, this is certainly good news, although it is not really "news" to most Doctor Yourself Newsletter readers. It is rather an official confirmation, one that has, finally, gotten the attention of the media. Even FOX news picked it up. As Gomer Pyle said, "Goll-y!")

Commentary by Bill Sardi
"With a growing body of evidence mounting, National Institutes of Health (NIH) researchers recently conceded that intravenous vitamin C may be an effective treatment for cancer. Last year the same researchers reported a similar study but the news media failed to publish it.
"The latest study, published in the Proceedings of the National Academy of Sciences, confirms the work of Nobel-Prize winner Linus Pauling who conducted cancer research in the 1970s with vitamin C. Dr. Pauling's studies were discredited at the time by poorly conducted research studies at the Mayo Clinic.

"NIH researchers made no mention of their earlier study in 2004 which showed that oral-dose vitamin C can achieve three times greater blood concentration than previously thought possible, a fact which negates the current Recommended Dietary Allowance for vitamin C. NIH researchers refuse to issue a retraction of their earlier flawed research which mistakenly claimed humans cannot benefit from high-dose oral vitamin C supplements."

More at
Also see:
Full citation:
Qi Chen, Michael Graham Espey , Murali C. Krishna, James B. Mitchell, Christopher P. Corpe, Garry R. Buettner, Emily Shacter, and Mark Levine. Pharmacologic ascorbic acid concentrations selectively kill cancer cells: Action as a pro-drug to deliver hydrogen peroxide to tissues. Proc. Natl. Acad. Sci. USA, 10.1073/pnas.0506390102

"Extracellular but not intracellular ascorbate mediated cell death, which occurred by apoptosis and pyknosis/necrosis . . . (T)hese data indicate that ascorbate at concentrations achieved only by i.v. administration may be a pro-drug for formation of H2O2, and that blood can be a delivery system of the pro-drug to tissues. These findings give plausibility to i.v. ascorbic acid in cancer treatment..."

This News release was provided by DOCTOR YOURSELF News (Vol. 5 , No. 13 for October, 2005)

No comments: